R&D Systems™ Recombinant Viral HCV E2, Carrier-Free
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 9146HC050
DescriptionThe Recombinant Viral HCV E2 Protein is derived from HEK293. The Recombinant Viral HCV E2 Protein has been validated for the following applications: Bioactivity.
The product is shipped at ambient temperature.
|Lyophilized from a 0.2μm filtered solution in PBS and NaCl|
|>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|Human embryonic kidney cell,HEK293-derived viral HCV E2 protein Glu384-Glu661,with a C-terminal 6-His tag|
|0.2 to 1.2μg/mL (ED 50)|
|C17orf33, chromosome 17 open reading frame 33, colony stimulating factor 3 (granulocyte), CSF3, CSF3OS, filgrastim, GCSF, G-CSF, GCSFlenograstim, granulocyte colony-stimulating factor, Lenograstim, MGC45931, pluripoietin|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|<0.10 EU per 1μg of protein by LAL method|
For Research Use Only